Načítá se...
Hypoglycemia in Sulfonylurea-Treated KCNJ11-Neonatal Diabetes: Mild-Moderate Symptomatic Episodes Occur Infrequently but None Involving Unconsciousness or Seizures
BACKGROUND: Neonatal diabetes (NDM) caused by mutations in KCNJ11 can be successfully treated with high dose oral sulfonylureas; however, little data is available on the risk of hypoglycemia. OBJECTIVE: Determine the frequency, severity, and clinical significance of hypoglycemia in KCNJ11-related ND...
Uloženo v:
| Vydáno v: | Pediatr Diabetes |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5918230/ https://ncbi.nlm.nih.gov/pubmed/29205704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pedi.12599 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|